沉默的肺损伤:急性呼吸困扰综合征没有胸部创伤在高水平跌倒后
Yu-Cheng Lo1, Shin-Lin Chiu2,3,4, Chiu-Liang Chen1,5
1Department of Orthopaedic Surgery, Changhua Christian Hospital, Changhua, Taiwan.
International medical case reports journal
|March 12, 2026
概括
一个罕见的急性呼吸困扰综合征 (ARDS) 病例发生在一个年轻的女性身上,后者经历了严重的脊柱骨折. 这突出了高能减速造成的肺损伤的潜在机制,而没有胸部创伤.
科学领域:
- 创伤外科手术是什么
- 肺部病理学 肺部病理学
- 关键护理医学 关键护理医学
背景情况:
- 急性呼吸窘迫综合征 (ARDS) 是一种严重的非心脏性呼吸衰竭.
- 它通常是在主要的系统性侮辱或创伤之后出现的.
- 肺是已知的ARDS的原因,通常与直接的胸部创伤有关.
研究的目的:
- 报告一个罕见的ARDS病例,该病例是由于高能降落造成的脊椎骨折.
- 探索潜在的未被认可的ARDS因减速损伤而导致的次要ARDS机制,而没有明显的胸部创伤.
- 强调严重创伤病例中呼吸系统监测的重要性.
主要方法:
- 一个17岁的女性的病例报告,腰部爆裂骨折和骨骨折.
- 最初和后续的胸部CT扫描,带有支气管支气管洗的支气管镜检查,心声学和广泛的微生物学测试.
- 临床监测血液动力学,液体平衡和炎症标志物.
主要成果:
- 患者在术后第二天出现ARDS,肺部扩散巩固和肺出血.
- 没有发现心脏病或感染性原因.
- 通过呼吸系统支持和炎症标志物的正常化来解决ARDS.
结论:
- 高能量的垂直减速可以导致隐性微血管肺损伤和ARDS,即使没有直接的胸部创伤.
- 这些机制造成的脊柱骨折可能与ARDS有关.
- 早期识别和呼吸系统监测对于治疗严重创伤和无法解释的呼吸系统困扰的患者至关重要.
相关概念视频
Acute Respiratory Failure-IV
663
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
663
Acute Respiratory Failure-I
1.3K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.3K
Acute Respiratory Failure-III
1.1K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.1K
Acute Respiratory Failure-II
1.4K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.4K
Flail Chest-II
820
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
820
Acute Respiratory Failure-V
591
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
591


